Skip to content

X-linked agammaglobulinemia



Immune system


General infections
Hypersensitivity reactions
Immune system organ disorders
Immune system pathology review

X-linked agammaglobulinemia


0 / 6 complete


1 / 1 complete
High Yield Notes
10 pages

X-linked agammaglobulinemia

6 flashcards

USMLE® Step 1 style questions USMLE

1 questions

A 4-year-old boy comes to the office because of recurrent bronchitis and ear infections for 3 years. His mother says that it all started a few months before his first birthday. Since then, he has had four or five ear infections a year. The boy’s grandfather had a similar condition and died of an overwhelming infection at a young age. Examination shows the child’s tonsils are barely visible, and laboratory investigations show a very low CD19 positive B-cell count. Which of the following is the pathogenesis of the most likely condition?

External References

Content Reviewers:

Rishi Desai, MD, MPH

With X-linked agammaglobulinemia, or XLA for short, gamma globulin is another name for immunoglobulin, which is another name for antibodies, a- means without, and -emia refers to the blood.

So this is a disease where there aren’t any antibodies in the blood, and X-linked means that it’s caused by a gene mutation on the X chromosome.

Now, normally, immunoglobulins are secreted into the blood by plasma cells, which are fully matured or differentiated B cells, a type of immune cell.

Way before that ever happens, though, those B cells start out in the bone marrow as pluripotent stem cells, pluripotent meaning that they can develop into a number of different types of cells.

But to become a B cell, first that pluripotent stem cell differentiates into a lymphoid precursor cell, then a pro-B cell, then a pre-B cell, then an immature B cell which migrates from the bone marrow to the spleen, where it becomes a mature or naive B cell, which after being exposed to the right antigen, moves into the blood or lymph and becomes an antibody-secreting plasma cell.

In XLA, this maturation process stops at the pre-B cell stage.

Why does it do that? Well, by the immature B cell stage, it has a B cell receptor, which is a membrane-bound antibody, specifically an immunoglobulin M or IgM.

But in the Pre- and Pro-B cell stages, this B cell receptor’s still being assembled, once it’s finished, it’s made up of heavy chain and light chain protein subunits, and the heavy chains are put together first.

Since it hasn’t been fully assembled yet, this IgM’s known as a pre-B cell receptor.

Now, an enzyme called bruton’s tyrosine kinase is super important for both the development and normal functioning of the B cell receptor.

With XLA, though, there’s a mutation in the BTK gene which makes the BTK enzyme ineffective.

And because of this ineffective BTK enzyme, the B cell maturation process gets stopped at this Pre-B cell stage, meaning no B cells leave the bone marrow, so ultimately people with XLA completely lack or have far fewer circulating B cells, and since B cells turn into plasma cells, which produce immunoglobulins or antibodies, they also lack circulating antibodies of all classes.

In the bone marrow, they might have normal or decreased levels of pre-B cells, with IgM heavy chains found in their cytoplasm.

X-linked agammaglobulinemia is a rare X-linked genetic disorder that affects the body's ability to fight infection. These patients do not generate mature B cells, which manifests as a complete lack of antibodies in their bloodstream. Patients typically present in early childhood with recurrent infections, in particular with extracellular, encapsulated bacteria.
  1. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Bates' Guide to Physical Examination and History Taking" LWW (2016)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "X-Linked Agammaglobulinemia Patients Are Not Infected with Epstein-Barr Virus: Implications for the Biology of the Virus" Journal of Virology (1999)
  7. "Autoimmunity in Primary Immunodeficiency Disorders: An Updated Review on Pathogenic and Clinical Implications" Journal of Clinical Medicine (2021)
  8. "Peripheral B Cell Deficiency and Predisposition to Viral Infections: The Paradigm of Immune Deficiencies" Frontiers in Immunology (2021)
  9. "B-cell biology and development" Journal of Allergy and Clinical Immunology (2013)